By NewsDesk @bactiman63
The Vermont Agency of Agriculture, Food and Markets (VAAFM) Animal Health section reports a horse in Alburgh tested positive for Equine Herpesvirus 1 (EHV-1), resulting in a case of Equine Herpesvirus Myeloencephalopathy (EHM).
The horse is currently under quarantine.
EHV-1 was recently identified as the cause of equine illness outbreaks in Florida and Europe and has led to the cancellation of several international equine events. No link between the Vermont case(s) and these outbreaks has been discovered.
As a precaution, Vermont horse owners should follow these basic biosecurity measures:
- All newly-purchased horses or horses that return to Vermont from events should be immediately isolated from other horses and quarantined for at least three weeks;
- All quarantined horses should be monitored for illness, including fever, cough, lack of appetite, nasal or ocular discharge, and/or swelling around the throat;
- All quarantined horses should have a temperature taken twice a day during the isolation period, and have separate thermometers for each quarantined horse;
- If a fever is recorded or signs of illness are noted, a veterinarian should be called immediately.
Horse-to-horse contact is the most common route of transmission of EHV-1, but it can also be transmitted when infectious materials, such as nasal secretions, are carried between infected and non-infected horses by people or on objects such as buckets, grooming tools, tack, etc. Fever is the most common clinical sign, along with coughing and nasal discharge. Although EHV-1 infection usually causes respiratory illness, some infected horses can also experience neurologic abnormalities such as incoordination, weakness, or inability to rise, a syndrome referred to as EHM.
- Reunion dengue epidemic intensifies
- Syphilis cases spike in the Syracuse area
- Salmonella outbreak sickens 28, Linked to ground turkey
- Hostess SnoBalls recall: Wrong packaging, undeclared Allergen
- About 8,000 babies are born with Chagas every year: PAHO
- Chikungunya Vaccine Candidate: Valneva completes recruitment for Phase 3 trial
- Yellow fever death recorded in Santa Catarina, Brazil
- CDC: Pause the use of the J&J COVID-19 vaccine until reviewed
- Congenital syphilis cases quadruple since 2015 in the US